Tetra Bio-Pharma (OTCQB:TBPMF; CSE:TBP) and the New Brunswick Health Research Foundation are investing $500,000 each over five years to establish a health research chair in cannabis at the University of New Brunswick.
The chair will focus on the study of biochemistry, medicinal use and pharmacology of cannabis. This research will expand UNB's commitment to research and innovation in the field of natural product and biomedical, health and life sciences, adding to its reputation as a leader in natural products' research.
Potential research areas for the chair include the analysis of existing cannabis literature, in order to understand inconsistencies and identify needs for future research; the biochemistry and medicinal chemistry analyses of cannabis; and preclinical pharmacology studies.
Funding for the chair is expected to start in the 2017-18 fiscal year.
Dr. Guy Chamberland, CSO of Tetra Bio-Pharma, said the company has partnered with the New Brunswick Health Research Foundation to help bring innovative cannabis-based therapies to patients.
“We have no doubt that when established, the work of this new chair will contribute significantly to this network by providing crucial information on the safety toward implementing new cannabis based products to practitioners working to help improve the quality of life for patients specifically living with chronic pain."